Pyrazinamide-induced sideroblastic anemia

American Journal of Hematology

Volumn 87, Issue 3, 2012, Pages 305-305

  Colucci, Giuseppe ^a   Silzle, Tobias ^a   Solenthaler, Max ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ERYTHROMYCIN ETHYLSUCCINATE; ETHAMBUTOL; HEMOGLOBIN; ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN;

ADULT; ALPHA THALASSEMIA; BONE MARROW; BONE MARROW BIOPSY; CASE REPORT; COOMBS TEST; DYSERYTHROPOIESIS; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; IRON STORAGE; IRON THERAPY; LIVER TOXICITY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; NOTE; PERITONITIS; PRIORITY JOURNAL; SIDEROBLASTIC ANEMIA;

5-AMINOLEVULINATE SYNTHETASE; ALPHA-THALASSEMIA; ANEMIA, SIDEROBLASTIC; ANTITUBERCULAR AGENTS; AZA COMPOUNDS; BONE MARROW; DRUG THERAPY, COMBINATION; DRUG-INDUCED LIVER INJURY; ETHAMBUTOL; FEMALE; HEMOLYSIS; HUMANS; ISONIAZID; MIDDLE AGED; PERITONITIS, TUBERCULOUS; PYRAZINAMIDE; PYRIDOXINE; QUINOLINES; RIFAMPIN;

EID: 84857051508     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22125     Document Type: Note

References (1)

1. Rovo A, Stussi G, Meyer-Monard S, et al. Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood. Int J Lab Hematol 2010;32: 329-335.